Study title: Open study with IK19 in 50 children and 50 adults.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Digestive System Diseases [C06] | |||||
Brands: Please see report, Please see report, Please see report, Please see report | |||||
MAH holders: Please see report, Please see report, Please see report, Please see report | |||||
Assessment: | |||||
Active substance: HYOSCINE BUTYLBROMIDE AND PARACETAMOL | |||||
ATC code: | |||||
Document link: Hyoscine Butylbromide+Paracetamol_U79-0384_synopsis.pdf | |||||
Document date: 2011-09-27 | |||||
Study number: U79-0384 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |